These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23127888)

  • 1. Azabenzthiazole inhibitors of leukotriene A₄ hydrolase.
    Tanis VM; Bacani GM; Blevitt JM; Chrovian CC; Crawford S; De Leon A; Fourie AM; Gomez L; Grice CA; Herman K; Kearney AM; Landry-Bayle AM; Lee-Dutra A; Nelson J; Riley JP; Santillán A; Wiener JJ; Xue X; Young AL
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7504-11. PubMed ID: 23127888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic properties of leukotriene A
    Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
    Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
    Han Y; Huang D; Xu S; Li L; Tian Y; Li S; Chen C; Li Y; Sun Y; Hou Y; Sun Y; Qin M; Gong P; Gao Z; Zhao Y
    Eur J Med Chem; 2021 Feb; 212():113028. PubMed ID: 33248848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
    Sandanayaka V; Mamat B; Bhagat N; Bedell L; Halldorsdottir G; Sigthorsdottir H; Andrésson T; Kiselyov A; Gurney M; Singh J
    Bioorg Med Chem Lett; 2010 May; 20(9):2851-4. PubMed ID: 20371179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
    Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.
    Meng H; Liu Y; Zhai Y; Lai L
    Eur J Med Chem; 2013 Jan; 59():160-7. PubMed ID: 23220644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
    J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
    Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
    Penning TD; Chandrakumar NS; Chen BB; Chen HY; Desai BN; Djuric SW; Docter SH; Gasiecki AF; Haack RA; Miyashiro JM; Russell MA; Yu SS; Corley DG; Durley RC; Kilpatrick BF; Parnas BL; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Krivi GG; Villani-Price D; Pyla EY; Smith WG
    J Med Chem; 2000 Feb; 43(4):721-35. PubMed ID: 10691697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, docking, cytotoxicity, and LTA
    El-Naggar MH; Mira A; Abdel Bar FM; Shimizu K; Amer MM; Badria FA
    Bioorg Med Chem; 2017 Feb; 25(3):1277-1285. PubMed ID: 28065501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
    Sun YN; Kim JH; Li W; Jo AR; Yan XT; Yang SY; Kim YH
    Bioorg Med Chem; 2015 Oct; 23(20):6659-65. PubMed ID: 26372074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
    Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
    Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors.
    Calışkan B; Banoglu E
    Expert Opin Drug Discov; 2013 Jan; 8(1):49-63. PubMed ID: 23095029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of benzofuran central cores for the inhibition of leukotriene A(4) hydrolase.
    Eccles W; Blevitt JM; Booker JN; Chrovian CC; Crawford S; de Leon AR; Deng X; Fourie AM; Grice CA; Herman K; Karlsson L; Kearney AM; Lee-Dutra A; Liang J; Luna R; Pippel D; Rao N; Riley JP; Santillán A; Savall B; Tanis VM; Xue X; Young AL
    Bioorg Med Chem Lett; 2013 Feb; 23(3):811-5. PubMed ID: 23260350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
    Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
    Hejazi L; Rezaee E; Tabatabai SA
    Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Malecha JW; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1137-9. PubMed ID: 12643929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
    ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.